MITCHELL RODEHEAVER: Open Payments
NPI 1558998211 · GONZALES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$368 in 14 payments from 5 companies in 2025. Trend: 2023 $15 · 2024 $121 · 2025 $368
Food & beverage: $368
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 5 | $165 |
| ABBVIE INC. | 3 | $79 |
| Supernus Pharmaceuticals, Inc. | 3 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
Products named: Auvelity, VRAYLAR, Qelbree, CAPLYTA, COBENFY.
Industry payments across LA — which companies pay providers there.
